We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.
Contact Talus Bio for detailed pricing information tailored to your specific needs and project requirements.
Talus Bio’s team is composed of experts in functional proteomics, automated biology, and machine learning, dedicated to pioneering new drug discovery methods for transcription factors.
Make undruggable targets a thing of the past
AI for enhanced functional proteins
PipeBio is a SaaS bioinformatics platform to develop antibody drugs.
Combinations therapy by rational design
We use human data and AI to develop better drugs faster.
AI platform accelerating therapies for rare & inflammatory diseases.
Multi-targeted therapeutics to treat complex diseases
Personalized drug discovery for blood cancer.
The robotic cloud laboratory for the life sciences.
Unleashing the potential of DNA and RNA based therapies using AI
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS